ELLEN HOPKINS: Open Payments
NPI 1952591463 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$456 in 17 payments from 11 companies in 2025. Trend: 2023 $243 · 2024 $413 · 2025 $456
Food & beverage: $356Education: $100
| Company | Payments | Amount |
|---|---|---|
| SEAGEN INC. | 1 | $100 |
| PFIZER INC. | 3 | $86 |
| GlaxoSmithKline, LLC. | 3 | $63 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Janssen Biotech, Inc. | 2 | $35 |
| Incyte Corporation | 1 | $28 |
| Exelixis Inc. | 1 | $25 |
| SERVIER PHARMACEUTICALS LLC | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| TAIHO ONCOLOGY, INC. | 1 | $18 |
Products named: TIVDAK, JEMPERLI, RYBREVANT, JAKAFI, CABOMETYX, Tibsovo, LYNPARZA, NINLARO.
Industry payments across FL — which companies pay providers there.
